Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02934880
Other study ID # CHB16.01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date April 2019

Study information

Verified date November 2017
Source Centre Henri Becquerel
Contact Olivier Rigal, MD
Phone +33276672241
Email olivier.rigal@chb.unicancer.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Breast cancer is the most frequent cancer in women in western countries. The improvement of therapeutic management associated to the developement of supportive care allows patient to live longer in better conditions. But several studies have showed the deleterious impact of treatment such as chemotherapy on cognition. To limit these damages, non therapeutic approaches such as Adapted Physical Activity (APA) have been developped.

The goal of this study is to evaluate the benefit of APA program on cognitive functions in patients with locally advanced breast cancer.


Description:

Patient with cognitive complaint will be randomized in two groups :

- Experimental group : Immediate APA program (after randomization)

- Standard group : Delayed APA program (3 months after randomization)

APA program contains 10 sessions of APA within five weeks (twice a week). Each session is composed of 5 exercises (each made of 3 serial of 7 repetitions in slow speed).

A cognitive and quality of life assessments will occur in two groups at 3 and 6 months after randomization.

The primary objective of the study is to evaluate the impact of APA program on the improvement of cognitive functions in patients with breast cancer who have been treated by adjuvant chemotherapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 152
Est. completion date April 2019
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women

- More than 18 years old

- Locally advanced breast cancer

- Patient who undergone surgery

- Cognitive complaint (FACT-COG inferior or equal to 8/16)

- No metastasis at the inclusion

- Patient who received adjuvant therapy by chemotherapy

- Patient with a social protection

- Barbizet scale Superior or equal to 3

- No neurological history

- No medical contraindication to APA

- Inform consent signed

Exclusion Criteria:

- Metastatic breast cancer

- History of other cancer (in 5 years before inclusion)

- Current chemotherapy or radiotherapy

- Chemotherapy or radiotherapy ended for more than 6 months

- Current APA program

- Blood transfusion for less than 6 mois

- Minimal mental score inferior to normal

- Patient no able to respond to the cognitive test

- Patient no able to realize APA program

- Drug use

- Alcohol abuse

- Patient Under guardianship or curatorship or deprived of liberty

Study Design


Related Conditions & MeSH terms


Intervention

Other:
immediate APA program
10 sessions of one hour APA in 5 weeks after patient randomization. 2 sessions per week will be organized
delayed APA program
10 sessions of one hour APA in 5 weeks 3 months after patient randomization. 2 sessions per week will be organized

Locations

Country Name City State
France Centre François Baclesse Caen
France Centre Oscar Lambret Lille
France Centre Henri Becquerel Rouen

Sponsors (1)

Lead Sponsor Collaborator
Centre Henri Becquerel

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary proportion of patient with an increase of Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG) result Proportion of patient with an increase superior or equal to seven points between FACT-COG at the inclusion and FACT-COG after APA program After APA program
Secondary Improval of quality of life Impact of APA on quality of life (FACT-B result) After APA program
Secondary Comparison of immediate APA and delayed APA on quality of life Comparison between FACT-B, FACT-COG and FACIT-F results in the two groups 30 months
Secondary Study of relations between cognitive functions and quality pf life Correlation between patient questionnaire and data of psychological tests done by neuropsychologist After APA program
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2